Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma

Mise à jour : Il y a 4 ans
Référence : NCT02631590

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to see if an experimental drug, called copanlisib is effective and safe in treating adult participants with cholangiocarcinoma, when used in combination with gemcitabine and cisplatin.


Critère d'inclusion

  • Biliary Carcinoma,Gall Bladder Carcinoma,Cholangiocarcinoma,Gastrointestinal Tumor

Liens